The Kousai Zhongshan R&D center opened at the Zhongshan Life Science Park on October 28.

The center covers an area of about 1,000 square meters. With one central laboratory and two pilot workshops, it can meet the needs related to the R&D, preparation and testing of dendritic cell vaccines for IIT clinical studies and the iterative upgrading of the company's world-leading Eco-Dc Vax platform.

Since its establishment in 2018, Kousai has been focusing on the R&D and industrialization of dendritic cell vaccines. "The Zhongshan R&D center will further enhance Kousai's research capabilities. Based in Zhongshan and embracing the Greater Bay Area, we will speed up our business layout and development in South China and even Southeast Asia," said Liu Huining, founder, chairman and CEO of Kousai.